Gliotransmission and brain glucose sensing critical role of endozepines

Diabetes

Volumn 62, Issue 3, 2013, Pages 801-810

  Lanfray, Damien ^a,b,c   Arthaud, Sébastien ^a,b   Ouellet, Johanne ^b,c   Compère, Vincent ^a,b,c,d,e,f   Do Rego, Jean Luc ^a   Leprince, Jérome ^a   Lefranc, Benjamin ^a,b,c   Castel, Hélène ^a,b,c   Bouchard, Cynthia ^g   Monge Roffarello, Boris ^g   Richard, Denis ^g   Pelletier, Georges ^e   Vaudry, Hubert ^a,b,c,e   Tonon, Marie Christine ^a,b,c   Morin, Fabrice ^a,b,c  

^a Université de Rouen   (France)

^b UNIVERSITY OF ROUEN   (France)

^c UNIVERSITÉ DE ROUEN   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITÉ LAVAL   (Canada)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; DIAZEPAM BINDING INHIBITOR; GLUCOSE; MELANOCORTIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; OCTADECANEUROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN GLUCOSE SENSING; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; FEEDING; GLIA CELL; GLIOTRANSMISSION; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE HOMEOSTASIS; HIPPOCAMPUS; HYPOTHALAMUS; LATERAL BRAIN VENTRICLE; MALE; METABOLIC DISORDER; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; TANYCYTE;

ANIMALS; APPETITE DEPRESSANTS; APPETITE REGULATION; APPETITE STIMULANTS; APPETITIVE BEHAVIOR; ARCUATE NUCLEUS; DIAZEPAM BINDING INHIBITOR; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; GLUCOSE; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; MALE; NERVE TISSUE PROTEINS; NEUROGLIA; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; RECEPTORS, MELANOCORTIN; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUES;

EID: 84874439635     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0785     Document Type: Article

References (41)

1. Blouet C, Schwartz GJ. Hypothalamic nutrient sensing in the control of energy homeostasis. Behav Brain Res 2010;209:1-12
2. Rossi M, Kim MS, Morgan DG, et al. A C-terminal fragment of Agoutirelated protein increases feeding and antagonizes the effect of a-melanocyte stimulating hormone in vivo. Endocrinology 1998;139:4428-4431
3. Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hypothalamus: A powerful stimulant of feeding behavior. Proc Natl Acad Sci U S A 1985;82:3940-3943
4. Bady I, Marty N, Dallaporta M, et al. Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding. Diabetes 2006;55: 988-995
5. Marty N, Dallaporta M, Foretz M, et al. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors. J Clin Invest 2005;115:3545-3553
6. Miselis RR, Epstein AN. Feeding induced by intracerebroventricular 2-deoxy-D-glucose in the rat. Am J Physiol 1975;229:1438-1447
7. Smith GP, Epstein AN. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol 1969;217:1083-1087
8. Parton LE, Ye CP, Coppari R, et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007;449: 228-232
9. Vidarsdottir S, Smeets PA, Eichelsheim DL, et al. Glucose ingestion fails to inhibit hypothalamic neuronal activity in patients with type 2 diabetes. Diabetes 2007;56:2547-2550
10. García MA, Millán C, Balmaceda-Aguilera C, et al. Hypothalamic ependymalglial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem 2003;86:709-724
11. Maekawa F, Toyoda Y, Torii N, et al. Localization of glucokinase-like immunoreactivity in the rat lower brain stem: For possible location of brain glucose-sensing mechanisms. Endocrinology 2000;141:375-384
12. Millán C, Martínez F, Cortés-Campos C, et al. Glial glucokinase expression in adult and post-natal development of the hypothalamic region. ASN Neuro 2010;2:e00035
13. Frayling C, Britton R, Dale N. ATP-mediated glucosensing by hypothalamic tanycytes. J Physiol 2011;589:2275-2286
14. Orellana JA, Sáez PJ, Cortés-Campos C, et al. Glucose increases intracellular free Ca(2+) in tanycytes via ATP released through connexin 43 hemichannels. Glia 2012;60:53-68
15. Sanders NM, Dunn-Meynell AA, Levin BE. Third ventricular alloxan reversibly impairs glucose counterregulatory responses. Diabetes 2004;53: 1230-1236
16. Chari M, Yang CS, Lam CK, et al. Glucose transporter-1 in the hypothalamic glial cells mediates glucose sensing to regulate glucose production in vivo. Diabetes 2011;60:1901-1906
17. Tonon MC, Leprince J, Gandolfo P, et al. Endozepines. In Handbook of Biologically Active Peptides. Kastin AJ, Ed/. Oxford, U.K., Elsevier, 2006, p 813-819
18. Compère V, Lanfray D, Castel H, et al. Acute food deprivation reduces expression of diazepam-binding inhibitor, the precursor of the anorexigenic octadecaneuropeptide ODN, in mouse glial cells. J Mol Endocrinol 2010;44:295-299
19. Tonon MC, Désy L, Nicolas P, Vaudry H, Pelletier G. Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides 1990;15:17-24
20. Loomis WF, Behrens MM, Williams ME, Anjard C. Pregnenolone sulfate and cortisol induce secretion of acyl-CoA-binding protein and its conversion into endozepines from astrocytes. J Biol Chem 2010;285:21359-21365
21. Masmoudi O, Gandolfo P, Leprince J, et al. Pituitary adenylate cyclaseactivating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. FASEB J 2003;17:17-27
22. Patte C, Gandolfo P, Leprince J, et al. GABA inhibits endozepine release from cultured rat astrocytes. Glia 1999;25:404-411
23. de Mateos-Verchere JG, Leprince J, Tonon MC, Vaudry H, Costentin J. The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. Eur J Pharmacol 2001;414:225-231
24. do Rego JC, Orta MH, Leprince J, Tonon MC, Vaudry H, Costentin J. Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: Evidence for an endozepinergic tone regulating food intake. Neuropsychopharmacology 2007;32:1641-1648
25. Compère V, Li S, Leprince J, Tonon MC, Vaudry H, Pelletier G. Effect of intracerebroventricular administration of the octadecaneuropeptide on the expression of pro-opiomelanocortin, neuropeptide Y and corticotropinreleasing hormone mRNAs in rat hypothalamus. J Neuroendocrinol 2003; 15:197-203
26. Lectez B, Jeandel L, El-Yamani FZ, et al. The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus. Endocrinology 2009; 150:2342-2350
27. Leprince J, Oulyadi H, Vaudry D, et al. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist. Eur J Biochem 2001;268:6045-6057
28. Malagon M, Vaudry H, Van Strien F, Pelletier G, Gracia-Navarro F, Tonon MC. Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain. Neuroscience 1993;57:777-786
29. Kurata K, Fujimoto K, Sakata T, Etou H, Fukagawa K. D-glucose suppression of eating after intra-third ventricle infusion in rat. Physiol Behav 1986;37:615-620
30. Cha SH, Wolfgang M, Tokutake Y, Chohnan S, Lane MD. Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake. Proc Natl Acad Sci U S A 2008;105:16871-16875
31. Fujita N, Sakamaki H, Uotani S, et al. Intracerebroventricular administration of insulin and glucose inhibits the anorectic action of leptin in rats. Exp Biol Med (Maywood) 2003;228:1156-1161
32. Hruby VJ, Lu D, Sharma SD, et al. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 1995;38:3454-3461
33. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995;44:180-184
34. Lam TK, Gutierrez-Juarez R, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 2005;309:943-947
35. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001;411:480-484
36. Tong Q, Ye CP, Jones JE, Elmquist JK, Lowell BB. Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat Neurosci 2008;11:998-1000
37. Barsh GS, Schwartz MW. Genetic approaches to studying energy balance: Perception and integration. Nat Rev Genet 2002;3:589-600
38. Seeley RJ, Drazen DL, Clegg DJ. The critical role of the melanocortin system in the control of energy balance. Annu Rev Nutr 2004;24:133-149
39. Grill HJ, Ginsberg AB, Seeley RJ, Kaplan JM. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J Neurosci 1998;18:10128-10135
40. Li G, Zhang Y, Rodrigues E, et al. Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss. Am J Physiol Endocrinol Metab 2007;293:E252-E258
41. Coppari R, Ichinose M, Lee CE, et al. The hypothalamic arcuate nucleus: A key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 2005;1:63-72